These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38249748)

  • 1. Dyskinesia-hyperpyrexia syndrome in Parkinson's disease triggered by overdose of levodopa - a case report and literature review.
    Du X; Wang X; Geng X
    Front Neurol; 2023; 14():1323717. PubMed ID: 38249748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Patient with Recurrent Dyskinesia and Hyperpyrexia Syndrome.
    Baek MS; Lee HW; Lyoo CH
    J Mov Disord; 2017 Sep; 10(3):154-157. PubMed ID: 28704983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinsonism-Hyperpyrexia Syndrome and Dyskinesia-Hyperpyrexia Syndrome in Parkinson's Disease: Two Cases and Literature Review.
    Wang JY; Huang JF; Zhu SG; Huang SS; Liu RP; Hu BL; Zhu JH; Zhang X
    J Parkinsons Dis; 2022; 12(6):1727-1735. PubMed ID: 35811538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dyskinesia-hyperpyrexia syndrome triggered by overdose of istradefylline: a case report].
    Komori S; Tsuboi T; Suzuki M; Nakamura T; Katsuno M
    Rinsho Shinkeigaku; 2022 Aug; 62(8):627-631. PubMed ID: 35871565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhabdomyolysis Associated with Severe Levodopa-Induced Dyskinesia in Parkinson's Disease: A Report of Two Cases and Literature Review.
    Pitakpatapee Y; Srikajon J; Sangpeamsook T; Srivanitchapoom P
    Tremor Other Hyperkinet Mov (N Y); 2021; 11():39. PubMed ID: 34692231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyskinesia-hyperpyrexia syndrome in Parkinson's disease: a systematic review.
    Wang M; Wang W; Gao Z; Yin X; Chen T; Jiang Z; Wang Z
    Clin Auton Res; 2021 Aug; 31(4):529-542. PubMed ID: 33826041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkinsonism-Hyperpyrexia Syndrome: A Case Series and Literature Review.
    Azar J; Jaber Y; Ayyad M; Abu Alia W; Owda F; Sharabati H; Zeid H; Khreshi S; AlBandak M; Sayyed Ahmad D
    Cureus; 2022 Sep; 14(9):e29646. PubMed ID: 36320988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dyskinesia-hyperpyrexia syndrome in a patient with Parkinson's disease: a case report].
    Taguchi S; Niwa J; Ibi T; Doyu M
    Rinsho Shinkeigaku; 2015; 55(3):182-4. PubMed ID: 25786757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinsonism-hyperpyrexia syndrome: A case report and review of literature.
    Grover S; Sathpathy A; Reddy SC; Mehta S; Sharma N
    Indian J Psychiatry; 2018; 60(4):499-503. PubMed ID: 30581218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case report: Reversible encephalopathy caused by dyskinesia-hyperpyrexia syndrome.
    Luo B; Zhang H; Qin L
    Front Neurol; 2023; 14():1234974. PubMed ID: 37645603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rhabdomyolysis as a complication of Parkinson's disease].
    Pozzoni P; Tentori F; Corti M; Pozzi C
    G Ital Nefrol; 2002; 19(1):13-7. PubMed ID: 12165940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatal hyperpyrexia after withdrawal of levodopa.
    Sechi GP; Tanda F; Mutani R
    Neurology; 1984 Feb; 34(2):249-51. PubMed ID: 6538021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rhabdomyolysis related to dyskinesia in Parkinson's disease.
    Bektaş H; Deniz O; Temel S; Keklikoğlu HD; Akyol S
    J Mov Disord; 2014 Apr; 7(1):25-7. PubMed ID: 24926408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dyskinesia-Hyperpyrexia Syndrome in Parkinson's Disease: A Heat Shock-Related Emergency?
    Sarchioto M; Ricchi V; Melis M; Deriu M; Arca R; Melis M; Morgante F; Cossu G
    Mov Disord Clin Pract; 2018; 5(5):534-537. PubMed ID: 30515444
    [No Abstract]   [Full Text] [Related]  

  • 15. A video-atlas of levodopa-induced dyskinesia in Parkinson's disease: terminology matters.
    Gupta HV; Lenka A; Dhamija RK; Fasano A
    Neurol Sci; 2024 Apr; 45(4):1389-1397. PubMed ID: 37987930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing Parkinson's disease with continuous dopaminergic stimulation.
    Wolters E; Lees AJ; Volkmann J; van Laar T; Hovestadt A
    CNS Spectr; 2008 Apr; 13(4 Suppl 7):1-14; quiz 15-6. PubMed ID: 18408654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep Brain Stimulation-Withdrawal Syndrome in Parkinson's Disease: Risk Factors and Pathophysiological Hypotheses of a Life-Threatening Emergency.
    Grimaldi S; Eusebio A; Carron R; Regis JM; Velly L; Azulay JP; Witjas T
    Neuromodulation; 2023 Feb; 26(2):424-434. PubMed ID: 36344398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An unwell patient with Parkinson's disease: Hyperpyrexia syndrome in a heatwave.
    Mooney E; Smith MD; Henderson EJ
    JRSM Open; 2022 Aug; 13(8):20542704221086162. PubMed ID: 35965941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ropinirole: a review of its use in the management of Parkinson's disease.
    Matheson AJ; Spencer CM
    Drugs; 2000 Jul; 60(1):115-37. PubMed ID: 10929932
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.